FDA.reportPublic FDA data

NDC 65757-302 - VIVITROL

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
65757-302
Package NDCs from labels
65757-302-02
Manufacturer
Alkermes, Inc. | Packaging Coordinators, LLC | Sharp Corporation
Effective date
2025-12-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
VIVITROL - Alkermes, Inc. | Packaging Coordinators, LLC | Sharp CorporationAlkermes, Inc. | Packaging Coordinators, LLC | Sharp Corporation2025-12-23HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65757-302-02VIVITROL4 mL in 1 VIAL, GLASSINJECTION, POWDER, FOR SUSPENSIO4 mL380 mg in 4mL38

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65757-302VIVITROL (NALTREXONE) KIT [ALKERMES, INC.]36Unmatched20240608_cd11c435-b0f0-4bb9-ae78-60f101f3703f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
naltrexoneACTIVE INGREDIENT5S6W795CQMVIVITROL (NALTREXONE) KIT [ALKERMES, INC.]14
naltrexoneACTIVE MOIETY5S6W795CQMVIVITROL (NALTREXONE) KIT [ALKERMES, INC.]14